Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

NCT07447817 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis
Post-polycythemia Vera Myelofibrosis
Post-essential Thrombocythemia Myelofibrosis

Interventions

DRUG: Pacritinib
DRUG: Selinexor

Sponsor

John Mascarenhas

Collaborators

[object Object]
[object Object]
[object Object]